Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists.

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...